Table 3.

Differences between EORTC QLQ-C30 ProCaSP data and norm data

	Baseline								24 months after baseline
	Radical prostatectomy		Radiotherapy				Radical prostatectomy		Radiotherapy
	nns	ns	total	brachy	comb	extern	nns	ns	total	brachy	comb	extern
Global quality of life	2.5	5.3	1.5	4.6	−1.7	1.3	5.3	10.3	2.0	3.8	2.8	0.1
Functioning scales
Physical	7.3	9.6	3.0	3.5	2.3	3.2	5.0	8.5	0.0	1.6	−1.3	−0.5
Role	9.7	14.0	3.6	11.0	2.3	12.2	9.7	14.1	4.6	−0.5	5.9	9.6
Emotional	−8.7	−9.3	−3.8	−2.8	−13.2	1.5	−1.6	4.4	−0.4	2.1	−2.7	−1.6
Cognitive	1.4	2.1	1.7	3.9	−1.5	2.1	−2.4	2.0	−1.6	0.8	−6.5	−0.2
Social	−3.1	−2.9	−4.9	−6.4	−13.1	2.4	−5.2	−1.8	−2.2	−7.5	1.9	1.5
Symptom scales
Fatigue	−10.0	−13.5	−6.9	−9.9	−0.4	−9.3	−4.5	−9.8	−3.4	−3.5	−1.5	−4.6
Nausea/Vomiting	−1.1	−1.7	0.4	1.8	1.9	−1.6	−0.8	−1.7	−0.6	0.8	−1.3	−1.6
Pain	−12.9	−19.0	−8.7	−8.3	−7.0	−10.5	−9.6	−14.0	−6.8	−5.4	−10.8	−9.4
Single items
Dyspnoea	−9.3	−9.0	−4.9	−9.6	−1.1	−3.3	−8.1	−4.9	−2.7	−6.5	−0.5	0.7
Insomnia	−2.8	−4.8	−1.2	−4.9	10.7	−6.6	0.1	−4.5	0.0	−4.0	10.6	−1.1
Appetite loss	−2.5	−2.0	−1.6	−3.5	0.6	−1.3	−2.8	−4.3	−0.5	−2.6	−3.8	3.5
Constipation	2.8	0.3	1.7	3.5	2.6	−0.4	1.9	−1.3	2.8	5.4	0.0	3.6
Diarrhoea	0.5	−2.1	3.6	1.7	8.4	2.1	0.4	−0.9	5.8	7.7	0.4	6.5
Financial difficulties	−6.7	−8.4	−3.1	−4.3	4.5	−7.4	−2.8	−6.1	−2.3	0.0	−4.5	−2.3

Legend: positive differences = higher mean functioning or higher mean symptom score in the prostate cancer patient group than in the norm data, negative differences = lower mean functioning or higher mean symptom score in the prostate cancer patient group than in the norm data.

Bold numbers indicate clinical relevance.

nns = non-nerve-sparing, ns = nerve-sparing, brachy = brachytherapy, extern = extern radiotherapy, comb = extern radiotherapy and brachytherapy.